Dr. Reddy’s
-
Franchise India Bureau Jan 03 2019 - 1 min readPayPal, the US-headquartered digital payments company, has posted more than twelve-fold jump in revenue generated by its Indian payments subsidiary to Rs 260 crore in the financial year 2018. In the previous year, the company had reported revenue of Rs 21 crore. PayPal’s net profit increased at a relatively modest pace during this period, up ...
-
Franchise India Bureau Oct 03 2018 - 1 min readDr Reddy’s Laboratories Ltd, the Hyderabad-based pharmaceutical major, has said that its wholly owned subsidiary Promius Pharma, LLC, has sold its rights of Cloderm Cream and its authorised generic to EPI Health, LLC. DRL said, "Promius Pharma, LLC, has sold its rights of Cloderm (clocortolone pivalate) cream, 0.1 per cent and its authorised generic to ...
-
Franchise India Bureau Apr 24 2018 - 1 min readDr Reddy's Laboratories has confirmed to have received an establishment inspection report (EIR) from the US health regulator after an audit of its UK facility. "With regard to the audit of our API Mirfield plant, United Kingdom, we would now like to inform you that we have received an establishment inspection report (EIR) ...
-
Franchise India Bureau Mar 26 2018 - 1 min readDr Reddy's Laboratories has launched Palonosetron Hydrochloride Injection, used in treating acute nausea and vomiting, in the US market. The Hyderabad-based firm launched the product after getting approval from the US Food and Drug Administration (USFDA), Dr Reddy's Labs said in a statement. The product is a generic version ...
-
Franchise India Bureau Mar 17 2018 - 1 min readDrug major Dr Reddy's Laboratories has claimed to have received four observations from US health regulator after inspecting its active pharmaceutical ingredients (API) facility in Telangana. Dr Reddy's in a regulatory filing said, "The audit of our API Hyderabad plant 1 at Jinnaram Mandal, Medak district, Telangana, by the USFDA has ...